Phase 1, Open-label, Safety and Feasibility Study of Implantation of Pf-05206388 (Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (Rpe) Living Tissue Equivalent) in Subjects With Acute Wet Age Related Macular Degeneration and Recent Rapid Vision Decline
Phase 1 trial of retinal pigment epithelium replacement in subjects with wet age-related macular degeneration in whom there is rapidly progressing vision loss
100 项与 PF-05206388 相关的临床结果
100 项与 PF-05206388 相关的转化医学
100 项与 PF-05206388 相关的专利(医药)
100 项与 PF-05206388 相关的药物交易